Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries

BACKGROUND AND OBJECTIVES: COVID‐19 convalescent plasma (CCP) has been used, predominantly in high‐income countries (HICs) to treat COVID‐19; available data suggest the safety and efficacy of use. We sought to develop guidance for procurement and use of CCP, particularly in low‐ and middle‐income co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vox Sang
Hauptverfasser: Bloch, Evan M., Goel, Ruchika, Wendel, Silvano, Burnouf, Thierry, Al‐Riyami, Arwa Z., Ang, Ai Leen, DeAngelis, Vincenzo, Dumont, Larry J., Land, Kevin, Lee, Cheuk‐kwong, Oreh, Adaeze, Patidar, Gopal, Spitalnik, Steven L., Vermeulen, Marion, Hindawi, Salwa, Van den Berg, Karin, Tiberghien, Pierre, Vrielink, Hans, Young, Pampee, Devine, Dana, So – Osman, Cynthia
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Original Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7323328/
https://ncbi.nlm.nih.gov/pubmed/32533868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vox.12970
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge